Literature DB >> 27680176

STATUS OF THE AMERICAN TEGUMENTARY LEISHMANIASIS IN THE STATE OF RIO DE JANEIRO , BRAZIL, FROM 2004 TO 2013.

Gilmar Ferreira Vita1, Maria Angélica Vieira DA Costa Pereira2, Ildemar Ferreira3, Argemiro Sanavria4, Celso Guimarães Barbosa5, Rita de Cássia Martins Aurnheimer6, Ericson Ramos de Mello3, Claudia Bezerra da Silva4, Rísia Brígida Gonçalves Cabral3.   

Abstract

The aim of the present study was to analyze the status of the American Tegumentary Leishmaniasis (ATL) in the state of Rio de Janeiro, from 2004 to 2013, through its spatiotemporal distribution. We also described variables considered relevant to the epidemiology of the disease, such as the clinical form, gender, ethnic group, age group, and progression of disease. This is a descriptive study, which used notified secondary data from the Brazilian Information System of Notifiable Diseases (SINAN), Ministry of Health, Brazil, regarding confirmed diagnoses. To help the calculation of coefficients of detection and mortality, we used population data from the Brazilian Institute of Geography and Statistics (IBGE). We analyzed 1,470 cases of ATL with the predominance of the cutaneous clinical form (1,292/87.89%). The data has also revealed seven deaths, a predominance of males (922/62.72%), and a higher incidence of ATL in the white ethnic group (731/49.72%). We observed a high incidence of ATL in the group of 20 - 39 years old (477/32.44%). We concluded that there was a decrease in the number of ATL cases in the state of Rio de Janeiro, based on a coefficient of detection of 1.44/100.000 inhabitants in 2004 decreasing to 0.20/100.000 inhabitants in 2013. The localities with the highest occurrences of ATL were the metropolitan region (843 cases) and the municipality of Rio de Janeiro (740 cases). In 2005, the highest incidence of the disease was observed (351 cases) in the study. Among the variables selected to describe the epidemiology of the disease, the following categories: cutaneous clinical form, male patients, white ethnic group, and the age group of 20 - 39 years old were more affected than the others.

Entities:  

Year:  2016        PMID: 27680176      PMCID: PMC5048642          DOI: 10.1590/S1678-9946201658071

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  18 in total

1.  [Spatial distribution of tegumentary leishmaniasis in the city of Rio de Janeiro].

Authors:  Helia Kawa; Paulo Chagastelles Sabroza
Journal:  Cad Saude Publica       Date:  2002 May-Jun       Impact factor: 1.632

2.  [Eco-epidemiology of cutaneous leishmaniasis in Buriticupu, Amazon region of Maranhão State, Brazil, 1996-1998].

Authors:  Luzenice Macedo Martins; José Manuel Macário Rebêlo; Márcio Costa Fernandes Vaz dos Santos; Jackson Maurício Lopes Costa; Antonio Rafael da Silva; Luiz Alves Ferreira
Journal:  Cad Saude Publica       Date:  2004-05-19       Impact factor: 1.632

3.  [Epidemiological and clinical study of 332 cases of cutaneous leishmaniasis in the north of Parana State from 1993 to 1998].

Authors:  Edilene Alcântara de Castro; Vanete Thomaz Soccol; Norberto Membrive; Ennio Luz
Journal:  Rev Soc Bras Med Trop       Date:  2002 Sep-Oct       Impact factor: 1.581

4.  Pentavalent antimonial treatment in mucosal leishmaniasis.

Authors:  R N Sampaio; J H Sampaio; P D Marsden
Journal:  Lancet       Date:  1985-05-11       Impact factor: 79.321

5.  [Leishmaniasis urbanization and low diagnosis capacity in the Metropolitan Region of Belo Horizonte].

Authors:  Z M Profeta da Luz; D N Pimenta; A L Cabral; V O Fiúza; A Rabello
Journal:  Rev Soc Bras Med Trop       Date:  2001 May-Jun       Impact factor: 1.581

6.  [Epidemiology of tegumentary leishmaniasis in São João, Manaus, Amazonas, Brazil].

Authors:  Jorge Augusto de Oliveira Guerra; Jéfferson Augusto Santana Ribeiro; Leíla Inês de Aguiar Raposo da Camara Coelho; Maria das Graças Vale Barbosa; Marcilene Gomes Paes
Journal:  Cad Saude Publica       Date:  2006-11       Impact factor: 1.632

7.  [Treatment of patients with American cutaneous leishmaniasis: health services evaluation in northwestern Paraná State, Brazil].

Authors:  Meiri Vanderlei Nogueira de Lima; Rosangela Ziggiotti de Oliveira; Airton Pereira de Lima; Magda Lúcia Oliveira Felix; Thais Gomes Verzignassi Silveira; Robson Marcelo Rossi; Ueslei Teodoro
Journal:  Cad Saude Publica       Date:  2007-12       Impact factor: 1.632

8.  [Mucosal complication of cutaneous leishmaniasis].

Authors:  Diego Fernando Zea; Martín Prager; Roger Adrian Figueroa; María Consuelo Miranda
Journal:  Biomedica       Date:  2009-03       Impact factor: 0.935

9.  [Geographic distribution and epidemiological features of American tegumentary leishmaniasis in old rural settlements in Paraná State, Southern Brazil].

Authors:  Wuelton Marcelo Monteiro; Herintha Coeto Neitzke; Maria Valdrinez Campana Lonardoni; Thaís Gomes Verzignassi Silveira; Maria Eugênia Moreira Costa Ferreira; Ueslei Teodoro
Journal:  Cad Saude Publica       Date:  2008-06       Impact factor: 1.632

10.  [A comparative study between the efficacy of pentamidine isothionate given in three doses for one week and N-methil-glucamine in a dose of 20mgSbV/day for 20 days to treat cutaneous leishmaniasis].

Authors:  Carmen Déa Ribeiro de Paula; João Herman Duarte Sampaio; Danielle Rizzo Cardoso; Raimunda Nonata Ribeiro Sampaio
Journal:  Rev Soc Bras Med Trop       Date:  2003-07-31       Impact factor: 1.581

View more
  3 in total

Review 1.  Leishmaniasis: a review.

Authors:  Edoardo Torres-Guerrero; Marco Romano Quintanilla-Cedillo; Julieta Ruiz-Esmenjaud; Roberto Arenas
Journal:  F1000Res       Date:  2017-05-26

2.  Male predominance in reported Visceral Leishmaniasis cases: Nature or nurture? A comparison of population-based with health facility-reported data.

Authors:  Kristien Cloots; Sakib Burza; Paritosh Malaviya; Epco Hasker; Sangeeta Kansal; Guy Mollett; Jaya Chakravarty; Nurpur Roy; Bibek Kumar Lal; Suman Rijal; Shyam Sundar; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2020-01-29

Review 3.  Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis.

Authors:  Endi Lanza Galvão; Ana Rabello; Gláucia Fernandes Cota
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.